Effects of tirzepatide, a dual GIP and GLP-1 receptor agonist, on blood pressure, cardiac function, and sympathetic nervous system in stroke-prone spontaneously hypertensive rats
Instead, researchers identified a potential link that warrants further investigation
At JosephCareRX, your health is our priority
| USA Pulses
To summarize several meta-analyses of CVOTs conducted with GLP-1RAs, it isconfirmed that based on 43 trials, GLP-1RAs are a class of efficacious agent for reducing MACE (MH-OR 0.87 [0.83, 0.92]), cardiovascular and all-cause mortality (MH-OR 0.89 [0.83, 0.96]) [48]
Due to cost, limited insurance coverage, and previous drug shortages, some people may consider compounded tirzepatide as an alternative to Zepbound